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Objectives. The purpose of this study was to det rmfne whether
the Impaired endothelium-depmdml vmodlladoa ofhypMemlve
patteoto b mated toa specfie defect of the musearlatc recepmar
to a broader abnormality of the vascular eadutiellum .
Background.
Patients with essential hypertension have abnor-
mal eadothellum-dcpeedeat vasodilator response to ncetylehdlee.
However, whether this results from an belated dysfunction of the
endatbefisl cell musprlnk receptor b unknown.
Mehodr. The responses of the foreman vaxxlature to acetyl.
cbolim and substance P (endo16etum-dependent agents acting on
different receptors) ad to sodium ultras (a direct dilator
of vascular smooth muscle) were studied h eight hypertensive
patients (six men, two womeui mean age l=SDI 50 t 12 years)
and eight nomad control subjects (four men, four women; mm
age 49 t 9 years). To determine the nitric oxide camdhudon to
substance P-Induced vasodWtloo, the vascular responses to sub-
stance P were also measured after inhibition of nitric oxide
synthesis with No-moaomethyl-L-mglmne
. Drugs were Intased
Into the brachial artery, and forearm blood flow was measured by
strain gauge plethysmograpby .
The critical role of the endothelium in the regulation of
vascular tone, and therefore in the homeostasis of the
cardiovascular system, has been emphasized by the demon-
stration of endothelial dysfunction in a number of cardiovas-
cular conditions, including systemic hypertension
. Thus,
previous studies have shown that the endothelium-
dependent vasodilator response to acetylcholine is blunted
in patients with essential hypertension
(1-5) and that this
abnormal response is independent of sympathetic (1,2) or
prostanoid (2) activity
. More recent studies have implicated
a decreased release of nitric oxide by endothelial cells as the
mechanism responsible for the impaired vascular responses
of hypertensive arteries (6,7) .
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Resabr. The response to acelykholiae was sigeifanily blunted
h hyperensive patients (highest blood low [men x SD] 8.4 ± 4
vs. 13
.8 s 4 ndlmln per 190 ml in control subjects, p < 0.03).
Similarly, the vasodgMer tiled of substance P was sig ifl aatly
reduced h hypMensive patients (bight blood low [men
3
SDI
8.8 t 4 a . 13.9 ± 4 dlmla per 106 ml h control sabjeets, p <
0.03). A slgnlfirat correlation was fazed between the maaimW
blood Sow with acetykhWhe and that with substance P (r = 0.68,
p < 0.006). The vasodiloor response to sod um dhopeumide am
dedW In patients and control subjects. The nitric oxide contri-
baNom to substance P-Wuced vmodfatlou was reduced h
hyper,
teadve patients, such that the responses to substance P memo ed
dnetu Wallets of 7W-maao•ehyl-L.argieiae were eat sga18-
eatly different between 16e two group .
Couchuionr
. Time gasp Indicate that the tadobeBY ab-
normaWy of patients with essential hypertension is not restricted
to the mwmrhk cell receptor.
(J Am Call Caudal 1994;23:7610-6)
Previous investigations of endothelial function in hyper-
tensive patients have invariably assessed endothelium-
dependent vascular relaxation by means of analyzing the
response of the vasculmure to the infusion of acetylcholine
(1-5), which, through a signal transduction pathway initiated
by stimulation of the muscarinic receptor, mediates the
release of nitric oxide
. However, recent evidence suggests
that atherosclerotic coronary arteries that have abnormal
responses to acetylcholine may show normal degrees of
vasodilation to substance P, another cndothcli
:m-dcpendent
vasodilator (8,9) . This may be because acetylcholine and
substance P act on different endothelial cell receptors
(10,11)
. These findings raise the possibility that the endothe-
[in] abnormality observed in certain cardiovascular condi-
tions may be an expression of a specific dysfunction of the
muscarinic receptor . Investigation of this hypothesis in
essential hypertension could lead to a more precise identifi-
cation of the mechanism of abnormal endothelium-
dependent vasodilation in this condition.
The purpose of the present study, therefore, was to
0735-tm70ers7 .0a
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determine whether the impaired vascular response to acetyl-
choline of hypertensive patients results from a selective
defect at the level of the muscarinic endothelial real receptor
or whether this is a consequence of a more generalized
abnormality of the vascular endothelium .
Methods
Study patients. Eight patients (six men, two women,
mean [±SD) age 50 ± 12 years) with a well documented
history of chronically elevated blood pressure (?1451
95 mm Hg) without any apparent underlying cause, who
were followed up at the outpatient department of the Na-
tional Heart, Lung, and Blood Institute, were recruited for
the study . Each patient had been treated for at least 5 years
with one or more antihypertensive agents . Medications
included calcium-channel blocking agents in five patients
(verapantil in three, and vfedipine in two), diuretic agents in
three, angiotensin-converting enzyme inhibitors in three
(enalapril in two, captopril in one) and beta-adrenergic
blocking agents in two (atenolol in both) . Four patients were
receiving one aolihypertensive agent, three patients were
taking two medications, and one patient was being treated
with three antihypertensive drugs . Patients were asked to
discontinue all antihypertensive medications 2 weeks before
the day of the study ; during that period they were closely
monitored for any evidence of accelerated or malignant
hypertension. Patients in whom the withdrawal of artihyper-
tensive agents was considered hazardous (mostly because of
severely elevated blood pressure despite medication) were
not included in the study . None of the patients had a history
of diabetes, hyperlipidemia, peripheral vascular disease,
coagulopathy or any disease predisposing them to vasculitis
or Raynaud's phenomenon .
A group of eight normal volunteers (four men, four
woolen ; mean age 49 ± 9 years), matched with the patients
for approximate age, was selected as a control group . Each
of these subjects was screened by clinical history, physical
examination, electrocardiogram, chest X-ray film and rou-
tine chemical analyses and had no evidence of present or
past hypertension, hyperlipidemia, cardiovascular disease or
any other systemic condition . None of the control subjects
was taking medications at the time of the study.
The most relevant clinical characteristics of the hyperten-
sive patients and normal control subjects are sul,unarized in
Table I
. Except for systemic blood pressure (measured at
the time of the study), no significant differences were ob-
served between the two groups .
All participants gave written informed consent for all
procedures. This study was approved by the National Insti-
tutes of Health Investigational Review Board .
Protocol. All studies were performed in the morning in a
quiet room with a temperature of -22°C (72°F) . Participants
were instructed to continue with their regular diet and were
asked to refrain from drinking alcohol or beverages contain-
ing caffeine and from smoking for at least 24 h before studies .
Table 1. Characteristics
of the Study Creep
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Normal Cannot Hypertensive
Subjects Patients
(n=8) (n=8) pValue
Each study consisted of infusion of drugs into the brachial
artery and the measurement of the response of the vascula-
ture. (changes in regional blood flow) by means of forearm
plethysmography . All drugs utilized in this study were
approved for human use by the Food and Drug Administra-
tion in the form of Investigational New Drug (IND) and were
prepared by the Pharmaceutical Developmental Service of
the National Institutes of Health after specific procedures to
ensure accurate bioavailability and sterility of the solutions.
While the participants were supine, a 20-gauge, 675-in .
(4 .4-cm) Teflon catheter (Arrow International Inc .) was in-
serted into the brachial artery of the nondomdnant arm (left, in
most patients) . This arm was slightly elevated above the level
of the right atrium, and a mercury-filled Silastic strain gauge
was placed on the widest part of the forearm (12,13). The strain
gauge was connected to a plethysmograph (model EC-4, D .E .
Hokanson) (14) c'Iibrated to measure the percent change in
volume; the plethysmograph in turn was connected to a chart
recorder to record the forearm flow measurements . For each
measurement, a cuff placed on the upper arm was inflated to
40 mm Hg with a rapid cuff inflator (model E-10, Hokanson) to
occlude venous outflow from the extremity. A wrist cuff was
inflated to suprasystolic pressures I min before each measure-
ment to exclude the hand circulation (15). Flow measurements
were recorded for -7 s every 15 s : seven readings were
obtained for each mean value .
Hasa! measurements were obtained at) :r a 3-min infusion
of 5% dextrose solution at I mllmin . Forearm flows were
then measured after the infusion of sot, tm nitroprusside,
acetylcholine and substance P . Sodium nitroprusside was
used as an endotheliam-independent substance because its
vasodilator effect is largely due to its direct action on smooth
muscle cells (16,17) . Acetylcholine and substance P, in
contrast, induce vasodilation by stimulating the release of
relaxing factors from the vascular endothelium (10,18)
. Ace-
tylcholine exerts its endothelium-dependent action by acting
on a muscarinic receptor (10), whereas substance P acts on
a tachykinin endothelial cell surface receptor (11) .
Age lye)
M,F
Mean
BP
fmv Hg)
Height (cm)
weight (kg)
Serum par slum
(wEq :lited
Serum sodium
(vEg1iterl
Creel/nonlmp,'
liler)
Cholesterol(rGdl)
49.5'`-9
414
82 .7 , 6
170 .1
x
12
78 .6'! 13
4.3 m 0.3
138.3 x 3
1.06-0
.2
165 .1 *- 35
50.1x12
612
120.1 x 12
168.2 x 9
82
.4 x 10
4 .1 x D'_
139 .D x 2
1 .10
168.0 t 43
NS
NS
10.001
NS
NS
NS
NS
NS
NS
Data presemedthemeenvalues ±SDornumberofpatients . HP
pressure: F = female ; 6t = male.
blood
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Sodium nitroprusside was infused at 0.8, 1 .6 and
3.2 ug1min, acetylcholine chloride (Sigma Chemical) at 7 .5,
15 and 30 pglmin and substance P (Sigma Chemical) at 1, 2
and 4 pmol/min (infusion rates 0.25, 0.5 and I mllmin,
respectively, for each drug) . Each dose was infused for
5 min, and forearm flow was measured during the last 2 min
of the infusion. A 30-min rest period was allowed, and basal
measurements were obtained before the infusion of each
drug. The sequence of administration of sodium rdtroprus-
side, acetylcholine and substance P was randomized to avoid
any bias related to the order of drug infusion
.
To determine the contribution of endothelium-derived
nitric oxide to substance P-induced vasodilation, the vascu-
lar responses to substance P were also measured after
administration of the arginine analog AI°-monomethyl-L-
arginine . This compound competitively inhibits the synthesis
of nitric oxide from L-arginine (I9) and thus permits the
assessment of the magnitude of release of nitric oxide under
basal conditions or during stimulation with endothelium-
dependent agents (6 7,20). For this purpose, after the three
dose-response curves previously mentioned were com-
pleted, another 30-min rest period ensued, and flow mea-
surements were obtained to corroborate return to basal
values. Then, the arginine analog N°-monomethyl-L-
arginine was infused at 4 pmoUmin (infusion rate, I mllmin)
for 5 min, and forearm blood flow was measured during the
last 2 min of the infusion. Subsr. - .ently, during continuous
infusion of N°-monomethyl-L-atginine, the cumulative dose-
response curve for substance P was repeated using the same
doses and infusion rates mentioned earlier .
During the study, the participants did not know which
drug was being infused. All blood pressures were recorded
directly from the intraarterial catheter immediately before
each measurement . Forearm vascular resistance was calcu-
lated as the mean arterial pressure divided by the forearm
blood flow .
Statistkalertalysis. Differences between Iwo mean values
were compared by paired or unpaired Student t test, as
appropriate . The responses to sodium nitroprusside, acelyl-
choline and substance P were compared by xalysis of
variance for repeated measures using a multiple linear re-
gression model that included dummy vI.tiables to correct for
between-subjects variability (21).
because basal forearm
blood flow was similar in patients and control subjects .
absolute values were used for air comparisons. However,
because the basal resistance war significantly different be
tween the two groups, changes is vascular resistance were
expressed as the percent of the 1wseline value for all coin-
parisons . Relation between variables were assessed by
means of the Pearson correlation coefficient and linear
regression analysis. All calculated p values are two-tailed .
All p values < 0.05 were considered to indicate significance .
All group data are reported as mean values t SD, unless
otherwise indicated .
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Fyne l. Forearm blood flow and vascular resistance responses to
acetylcholine in eight normal control subjects and eight hyperten-
sive patients . Data represent mean values and SEN
.
Results
Vascular ropoanes to anlykieline, saMtance P and
sodlw nhroprualde. None of the drags utilized in this inves-
tigation produced any change in systemic blood pressure .
Confirming the results obtained in previous studies
(1 .2),
the increase in blood flow and decrease in vascular resis-
tance with acetylcholine were significantly reduced in hyper-
tensive patients compared with normal control subjects (Fig .
I). At the highest dose (3011g!min), forearm blood flow was
13.8 ± 4 and 8.4 ± 4 mllmin per 100 ml in control subjects
and patients, respectively (p < 0 .03) .
Similar to the results obtained with acetylcholine, the
increase in blood flow and decrease in vascular resistance
;educed by substance P were significantly blunted in hyper-
tensive patients compared with normal control subjects (Fig .
2)
. At the hi, test dose (4 pmoUmin), forearm blood flow was
13 .9 a 4 and 8.8 ± 4 mVtnin per 100 ml it,, control subjects
and patients, respectively (p < 0 .03) . Of nuts, a significant
correlation was found between the highest blood tow re-
sponses with acetylcholine and with substance P (r = 0
.68)
(Fig. 3) .
No significant differeaces were found between the two
groups in the forearm blood flow and vascular resistance
responses to sodium nitroprusside (Fig
. 4)
. At the highest
dose (3.2
As/min),
forearm blood flow was 9
.3 a 2 and 8.9 *_
2 mVmin per 100 ml in control subjects and hypertensive
patients, respectively . No correlation was found between
the maximal blood flow with either acetylcholine or sub-
JACC vel . 23. No. 7
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Soteance P
(pmovmin)
Fteare 2. Forearm blood flow and vascular resistance responses to
substance Pin eight normid control subjects and eight hypertensive
patients . Data represent mean values and SEM .
stance P and that measured during infusion of sodium
nitroprusside (r = 0 .05 and -0.03, respectively).
Effect of the argWoe analog 1V °-manomethyl-L-arginine.
Before infusion of N'-monomethyl-L-arginine, the basal
forearm blood flow was similar in hypertensive patients and
normal control subjects (2.64'_ 0.6 Vs . 2.88 ± 0.8 mUmin per
100 ml, respectively)
. As expected, the basal vascular resis-
tance was significantly elevated in patients compared with
control subjects (49.9 ± 14 vs. 32 .3 ± 10 mm lig/ml per min
per ml, p < 0.03) .
The infusion of N ° -monomethyl-L-arginine proms'c,,i a
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Figure
4 . Forearm blood flow and vascular resistance responses to
sodium nitroprusside in eight normal control subjects and eight
hypertensive patients . Daia represent mean values and SEM .
significant decrease its blood flow and an increase in vascular
resistance in both groups . In hypertensive patients, blood
flow decreased from 2.64 ± 0.6 to 2.14 ± 0.5 mVmin per
100 ml (p < 0.05) . and vascular resistance increased from
49.9
1
14 to 62 .3 ± 20 mm Hglml per min per ml (p < 0 .05).
In normal control subjects, blood flow decreased from
2
.88 ± 0 .8 to 1 .88 ± 0.6 ml/min per 100 ml (p < 0 .001), and
vascular resistance increased from 32 .3 ± 10 to 50.6
18 mm Hg/ml per min per rid (p < 0.01) . The magnitude of
changes in blood flow and vascular resistance with N°-
monomethyl-L-arginine was significantly greater in normal
control subjects than in hypertensive patients (decrease in
Figure 3. Relation between maainlal forearm blond flow
measurements obtained during infusion of acetylcholine
(30 pg/min) and substance P (4 pmotlmin) in eight normal
control subjects (open eireles) and eight hypertensive pa-
tients (solid circles).
1614
	
PANZA ET AL.
ENDOTHELIUM-DEPENDENT VASODILATION IN HYPERTENSION
Figure S. Relation between the vascutar effects of N°-
monomethyl-L-arginine
(L-NMMA) and substance P
(4 pmol/min) in eight normal control subjects (open elides)
and eight hypertensive patients (solid denim) .
blood flow was 1 .01 ± 0 .4 vs . 0.49 ± 0.2 ml/min per 100 ml,
respectively, p < 0 .02, and increase in resistance 57 ± 30%
vs. 24 ± 11%, respectively, p < 0.03) .
A significant correlation was observed between the effect
of N°-monomethyl-L-arginine and the vascular response to
substance P (r = 0.63) (Fig . 5) . A similar correlation was
found between the effect of N °-monomethyl-L-arginine and
the increase in blood flow induced by acetylcholine (r =
0 .55, p < 0.03) . However, no correlation was observed
between the effect of N ° -monomethyl-L-arginine and the
vascular response to sodium nitroprusside (r = 0.23, p =
NS).
The arginine analog N ° -monomethyl-L-orginine signifi-
cantly blunted the response to substance P both in normal
control subjects and hypertensive patients . In normal control
subjects, at the highest dose of substance P (4 pmol/min), blood
flow was reduced from 13 .9 t 4 before to 9.5 t 2 ml/min per
100 ml after infusion of N°-monomethyl-L-argirone (p < 0.005) .
In hypertensive patients, the highest blood flow with sub-
stance P decreased from 8.8 ± 4 before to 7
.6 ± 4 after
ml/min per 100 ml infusion of the arginine analog (p < 0
.03) .
Of note . the effect of N°-
monomethyl-Larginine on the
vasodilator effect of substance P was more pronounced in
normal control subjects than in hypertensive patients (per-
cent decreases in blood flow at each dose of substance P
were 50 t 19%, 47 ± 17% and 33 ± 8% in normal control
subjects and 26
t 9%, 28 ± 12% and 12
t
6% in hyperten-
sive patients, p < 0
.01 by analysis of variance for repeated
measures) . Consequently, the vascular responses to sub
stance P measured
after
the infusion of N°-monomethyl-L-
arginine were not significantly different between normal
control subjects and hypertensive patients (Fig . 6). A signif-
icant correlation was found between the decrease in blood
flow induced by the arginine analog at baseline and its effect
on the vascular response to substance P (r = 0 .51, p < 0.05).
No significant changes in systemic blood pressure were
observed with the infusion of N
°-monomethyl-L-arginine in
either hypertensive patients or normal control subjects
.
JACC V.I. 23 . No.7
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Discussion
The purpose of the present investigation was to determine
whether the blunted vasodiator response to the endothelium,
dependent agent acetylcholine previously demonstrated in
patients with essential hypertension (I-5) is an expression of
a selective abnormality at the level of the muscarinic recep-
tor of
endothelial
cells leading to reduced stimulation for
nitric oxide synthesis.
Vasedar reapoaae to snbatrce P. One results demon-
strate that patients with essential hypertension also have a
Figue f. Forearm blood Bow and vascular resistance responses to
substance P measured after admini
.Wioo of N°-monomethyl-L-
arginine (LNMMA) in eight normal control subjects and eight
hypertensive patients. Data represent mean values and SEM .
;ACC Val . 23, No. 7
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reduced vasodilator response to r_bstance P, a compound
that induces the release of nitric oxide and thereby causes
vascular relaxation by a receptor other than that which medi-
ates the response to acetylcholine (I1) . These findings indicate
that the previously reported impairment in endothelium-
dependent vasodilation of hypertensive patients is not re-
lated to a localized abnormality at the erdothelial cell
muscaritcc receptor level and must therefore be an expres-
sion of a more generalized defect of the vascular endothe-
lium in response to diverse stimuli .
Role of endothelium: derived nitric oxide. That this defect
is at least partly related to reduced bioavailability of nitric
oxide is supported by analysis of the effect of N°-
monomethyl-L-arginine, an inhibitor of endothelial synthesis
of nitric oxide (19,20), on the vascular response to substance
P . Thus, N°-monomethyl-L-arginine significantly blunted
the vasodilation induced by substance P, and this signifi-
candy correlated with the effect of the arginine analog on
basal hemodynamic variables . Of note, the effect of N°-
monomethyl-L-arginine on the vascular response to sub-
stance P was diminished in hypertensive patients, indicating
that the release of nitric oxide in response to substance P
must be reduced in these patients and was therefore less
affected by inhibition of its synthesis . Indeed, the vasodila-
tor effect of substance P after administration of N°-
monomethyl-L-arginine was not significantly different be-
tween hypertensive patients and normal control subjects
.
Previous studies from our laboratory have demonstrated a
similar effect of No
-monomethyl-L-arginine on the response
to acetylcholine in hypertensive and normotensive humans
(7) ; the response to sodium nitroprusside, however, was not
modified in either group (7), indicating that this effect of the
arginine analog is sp.eific for endothelium-dependent va-
sodilators.
It must be noted that in both hypertensive patients and
normal control subjects, the vasodilator effect of substance P
was only partially reduced by N°-monomethyl-L-arginine,
suggestLsg that other substances, such as endothelium-
derived hyperpolarizing factor (22,23), may be released by
the endothelium in response to substance P and contribute
importantly to its vasodilator action, Also, the inhibition of
nitric oxide synthesis by N ° -monomethyl-L-arginine may
have been only partial, thus allowing some release of nitric
oxide in response to substance P despite the administration
of the arginine analog
. Finally, animal studies have shown
that an
increased release of a vasoconstrictor prostanoid
may play an important role in the endothelium-dependent
vascular responses of hypertensive arteries (24-26)
. Al-
though our findings cannot definitely rile out the possibility
that such a mechanism operates in human hypertension, the
results of the present study suggest that a reduced bioavail-
ability of nitric oxide largely accos its for the abnormal
rtdothefinm-dependent vasodilation in hypertensive pa-
Cents because the response to substance P otter inhibition of
nitric oxide synthesis was not different between patients and
control subjects.
1615
Location of the endothelial abnormality. The concept of
an abnormality of the vascular endothelium in hypertension
that extends beyond the muscarinic receptor level is further
substantiated by two other independent findings of the
present study . First, a significant correlation was found
between the vasodilator responses to acetylcholine and
substance P in our study subjects. This suggests that the
impaired ability of the vasculature to respond to these
stimuli is related to a common mechanism. Thus, the defect
is presumably located in the pathway that leads to nitric
oxide production, at a point distal to the different receptors
that are activated by each agent . Alternatively, the defect
may reside in the endothelial cell membrane and involve
both the muscarinic and tachykinin receptors . Second. the
effect of N°-monomethyl-L-arginine on basal vascular tone
was reduced in hypertensive patients compared with normal
control subjects . This observation, which is in agreement
with previous reports from our and other laboratories (6,7) .
is consistent with a diminished release of nitric oxide by
hypertensive arteries in the basal state, a condition that may
contribute importantly to the pathophysiology of systemic
hypertension
. It appears that this diminished nitric oxide
production determines the impaired endothelium-dependent
vasodilation of hypertensive patients, as suggested by the
correlation between the effects of N°-monomethyl-L-
arginine on basal hemodynamic variables and the vascular
responses to both substance P and acetylcholine .
Of note, the endothelium-dependent vascular relaxation
to substance P is preserved in human coronary arteries with
vasoconstrictor responses to acetylcholiae (8 .9) and in the
forearm vasculature of patients with congestive heart failure
(27). Thus, the observation of a depressed response to
substance P in hypertensive patients may result from either
distinct mechanisms of endothelial dysfunction in different
cardiovascular conditions or different behavior of the vascu-
lar beds under investigation.
Our findings of reduced vasodilator responses to both
acetylcholine and substance P in hypertensive patients thus
rule out the possibility of a specific defect at the endothelial
cell muscarinic receptor level
. Furthermore, the observation
that the response to sodium nitroprusside was similar in both
subject groups indicates that the impaired responses of
hypertensive arteries are not a consequence of a nonspecific
defect in the responsiveness of the vascular smooth muscle
(1,2). However, the design of our study does not allow us to
determine the precise location of the defect in the nitric
oxide system that leads to abnormal endothelium-dependent
vascular relaxation in hypertension . Such a defect may
reside in the endothelial cell membrane, in the intracellular
signal transduction pathway, in the enzyme responsible for
synthesizing nitric oxide, in the release of nitric oxide from
the endothelial cell or in the breakdown of nitric oxide. Each
of these possibilities merits further investigation .
Conclusions. The present study demonstrates that patients
with essential hypertension have impaired endothelium-
dependent vasodilator responses to both acetylcholine and
1616
	
PANZAETAL.
ENDOTHELIUM-DEPENDENT
VA50DILATION IN HYPERTENSION
substance P, indicating that the endothelial abnormality in
this condition is not restricted to the muscarinic receptor.
These findings expand our knowledge
of the pathophysiol-
ogy of endothelial dysfunction in essential
hypertension and
emphasize the need for continued investigation in this area
to more precisely identify the mechanisms of disease that
contribute to the initiation or perpetuation of the hyperten-
sive process.
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